Since the 5-gene signature is higher in TNBC, we analyzed outcomes in the defined molecular subtypes of breast cancer in METABRIC by sub-grouping patients into ER+, HER2+, and TNBC subtypes of breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.